Extracorporeal affinity adsorption methods for the treatment of

Details Extracorporeal affinity adsorption methods for the treatment of Extracorporeal affinity adsorption methods for the treatment of

1993-07-23

1998-05-19

Saunders, David

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Extracorporeal or ex vivo removal of antibodies or immune...

210638, 210645, 210646, 210648, 210651, 210660, 210661, 210670, 210688, 604 5, 604 6, A61K 3900, A61M 3700, B01D 1508

Patent

active

057532273

ABSTRACT:
Extracorporeal affinity adsorption treatments which are aimed at the substantial removal of two or more compounds that are etiological in the pathogenesis of diseases in man provide effective therapeutic intervention means for these diseases. The methods are particularly suitable for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases. Extracorporeal chelation and immunotherapy for atherosclerosis, extracorporeal chelation treatment with on-line regeneration or replacement of chelant, extracorporeal immunotherapy with antibody fragments, and extracorporeal immunoadsorption utilizing antibodies bound to Protein A are also disclosed.

REFERENCES:
patent: 3453194 (1969-07-01), Bennett et al.
patent: 4215688 (1980-08-01), Terman et al.
patent: 4228015 (1980-10-01), De Vries et al.
patent: 4375414 (1983-03-01), Strahilevitz
patent: 4612122 (1986-09-01), Ambrus et al.
patent: 4614513 (1986-09-01), Bensinger
patent: 4627915 (1986-12-01), Kuroda et al.
patent: 4637880 (1987-01-01), Halbert
patent: 4714556 (1987-12-01), Ambrus et al.
patent: 4737544 (1988-04-01), McCain et al.
patent: 4813924 (1989-03-01), Strahilevitz
patent: 4820261 (1989-04-01), Schmoll et al.
patent: 5061237 (1991-10-01), Gessler et al.
patent: 5091091 (1992-02-01), Terman
patent: 5196324 (1993-03-01), Bumol et al.
patent: 5258503 (1993-11-01), Yokohari et al.
patent: 5474772 (1995-12-01), Maddock
patent: 5626843 (1997-05-01), Skurkovich et al.
P. Aebischer et al., J. Biomech Eng., vol. 113 (2), 1991, pp. 178-183.
M. Amato et al., The International Journal of Artificial Organs, vol. 11 (3), 1988, pp. 175-180.
B.A. Bansal et al., Cancer, vol. 42, No.1, 1978, pp. 1-18.
R.E. Bird et al., Science, vol. 242, 1988, pp. 423-442.
H. Borberg et al., Journal of Clinical Apheresis, vol. 4, 1988, pp. 59-65.
T. Bratt and S. Ohlson, J. Clin. Lab. Immunol., vol. 27, 1988, pp. 191-195.
G. Brown et al., New England Journal of Medicine, vol. 323(19), Nov. 8, 1990, pp. 1289-1298.
E. Cranton, "Bypassing Bypass," Hampton Road Publishers, Norfolk, Virginia, 1992.
P.D.G. Dean et al., Ed., "Affinity Chromatography: A Practical Approach," IRL Press, Oxford 1985, pp. 1-73.
J. Goding et al., J.Immunological Methods, vol. 20, 1978, pp. 241-253.
C. Hartmann et al., Journal of Pharmacokinetics and Biopharmaceutics, vol. 19(4), 1991, pp. 385-403.
J.L. Held et al., Journal of American Academy of Dermatologists, vol. 28, 1993, pp. 253-254.
V. Hombach et al., Dtsch Med. Wschr, vol. 111(45), 1986, pp. 1709-1715.
R.A. Houghten, Proc. National Academy of Science USA, vol. 82, Aug. 1985, pp. 5131-5135.
D.J. King et al., Antibody, Immunoconjugates, and Radiopharmaceuticals, vol. 5(2), 1992, pp. 159-170.
T. Kita et al., Proceedings of the National Academy of Sciences USA, vol. 84, 1987, pp. 5928-5931.
J.W. Larrick, Pharmacological Reviews, vol. 41 No. 4, 1989, pp. 539-557.
J.L. Lear et al., Radiology, vol. 179, 1991, pp. 509-512.
R. Lindmark et al., J. Immunol. Methods, vol. 62, 1983, p. 1.
D.J. Lupien et al., Pediatric Res., vol. 14, 1980, pp. 113-117.
L. Marcus et al., American Heart Journal, vol. 110, No. 1, Part 1, Jul. 1985, pp. 30-39.
S.K. Mujais and P. Ivanovich, in "Replacement of Renal Function by Dialysis", Third Edition. Kluwer Academic Pub., J.F. Maher Editor, 1989, pp. 181-198.
K. Norrgren et al., Antibody Immunoconjugates and Radiopharmaceuticals, vol. 4(4), 1991, pp. 907-914.
A. Odaka et al., International Journal of Artificial Organs, vol. 9, 1986, pp. 343-348.
J.H. O'Keefe, Jr. and B.D. McCallister, Editorial, Mayo Clinic Proceedings, vol. 67, 1992, pp. 389-391.
E. Olszewer and J.P. Carter, Medical Hypotheses, vol. 27(1), Sep. 1988, pp. 41-49.
R.E. Ostlund, Jr., Artificial Organs, vol. 11(5), 1987, pp. 366-374.
J. Regnstrom et al., Lancet, vol. 339, No. 8803, May 16, 1992, pp. 1183-1186.
E.B. Rimm et al., New England Journal of Medicine, vol. 328(20), May 20, 1993, pp. 1450-1456.
J.T. Salonen et al, Lancet, vol. 339, No. 8798, Apr. 11, 1992, pp. 883-887.
J.T. Salonen et al., Circulation, vol. 86(3), Sep. 1992, pp. 803-811.
H. Savin et al., American Heart Journal, vol. 113(5), May 1987, pp. 1078-1084.
D. Seidel et al., Journal of Clinical Apheresis, vol. 4, 1988, pp. 78-81.
R.D. Simari et al., Mayo Clinic Proceedings, vol. 67, Apr. 1992, pp. 317-322.
M.J. Stampfer et al., New England Journal of Medicine, vol. 328(20), May 20, 1993, pp. 1487-1489.
M. Strahilevitz, Atherosclerosis, vol. 26, 1977, pp. 373-377.
M. Strahilevitz, Lancet, vol. 340, Jul. 25, 1992, p. 235.
G.R. Thompson, Lancet, 1981 1, pp. 1246-1248.
A.M. Wallace and A. Wood, Clinical Chimica Acta, vol. 140, 1984, pp. 203-212.
G.W. Welling et al., Journal of Chromatography, vol. 512, 1990, pp. 337-343.
R.L. Wingard et al., American Journal of Kidney Diseases, vol. 18(5), 1991, pp. 559-565.
S.R. Wirebaugh and D.R. Gerates, DICP, vol. 24(1), Jan. 1990, pp. 22-24.
R. Yang et al., Antibody, Immunoconjugates and Radiopharmaceuticals, vol. 5, 1992, pp. 201-207.
S. Yokoyama et al., Arteriosclerosis, vol. 5, Nov./Dec. 1985, pp. 613-622.
Mackh's Chemical Dictionary, McGraw Hill, Inc., 1969, p. 148.
L. E. Hood et al, Immunology, Benjamin/Cummings Publishing Company, Inc., 1984, pp. 519-522.
I Schenkein et al, Jour. Clin. Invest., 50, 1864-1868, 1971.

Affiliated with

Also associated with

Rating

Extracorporeal affinity adsorption methods for the treatment of does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Extracorporeal affinity adsorption methods for the treatment of , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extracorporeal affinity adsorption methods for the treatment of will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1850360